Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway.

about

Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway.

Item

http://www.wikidata.org/entity/Q48186804

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pioglitazone inhibits cancer c ...... a a PPARγ-independent pathway.

@en

Pioglitazone inhibits cancer c ...... a a PPARγ-independent pathway.

@nl

type

Item

label

Pioglitazone inhibits cancer c ...... a a PPARγ-independent pathway.

@en

Pioglitazone inhibits cancer c ...... a a PPARγ-independent pathway.

@nl

prefLabel

Pioglitazone inhibits cancer c ...... a a PPARγ-independent pathway.

@en

Pioglitazone inhibits cancer c ...... a a PPARγ-independent pathway.

@nl

P1476

Pioglitazone inhibits cancer c ...... ia a PPARγ-independent pathway

@en

P2093

Keishi Kawashima

http://www.w3.org/2001/XMLSchema#string

Masanobu Tsubaki

http://www.w3.org/2001/XMLSchema#string

Motohiro Imano

http://www.w3.org/2001/XMLSchema#string

Takao Satou

http://www.w3.org/2001/XMLSchema#string

Tatsuki Itoh

http://www.w3.org/2001/XMLSchema#string

Tomoya Takeda

http://www.w3.org/2001/XMLSchema#string

Yoshika Tomonari

http://www.w3.org/2001/XMLSchema#string

P2860

Survivin: a unique target for tumor therapy

AIF: not just an apoptosis-inducing factor

The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.

PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma

Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.

YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice

PPARgamma-independent antitumor effects of thiazolidinediones.

Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.

P304

3638-3647

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.26225

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

Shozo Nishida

P577

2017-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29030979

http://www.w3.org/2001/XMLSchema#string